Indeed, exosomal transfer of tumor-derived EGFR to both local and distant recipient cells has been found to promote cancer cell growth, metastases and drug resistance as well as angiogenesis, metastatic niche formation, and suppression of anti-tumor immunity (13, 95, 105). The gene discussed is EGFR; the disease is cancer.